TORONTO, ONTARIO--(Marketwired - Jan. 23, 2014) - Prism Medical Ltd., ("Prism Medical" or "the Company") (TSX VENTURE:PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced a change in senior management roles. Prism Medical UK has developed well over the last few years and is now in a position where there are significant opportunities to grow the business and maximize shareholder value. As result Stuart Meldrum has agreed to again lead the UK team as its CEO in an effort to maximize these opportunities. Andy McIntyre will assume the CEO responsibilities in addition to his current responsibilities as Executive Chairman.
"Stuart has made tremendous contributions to the Company in his role as CEO and will continue to be an integral member of the leadership team in his new role," said Andy McIntyre, Executive Chairman of Prism Medical. "We see significant opportunities in the UK to maximize shareholder value. Stuart and I agreed that his intimate knowledge of that market puts him in a unique position to exploit these opportunities that no one else in the Company could execute."
On these changes Stuart Meldrum commented, "I am very excited to be returning to the UK and working closer with everyone on the UK team. The potential for the UK business is quite significant and I believe that by working together and leveraging our significant knowledge, experience and resources we will make Prism UK into an even greater company."
About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of durable medical equipment and related services to the mobility challenged in Canada, the US and the UK, with more than 100,000 installations and 200,000 product solutions sold. The Prism Medical brands include Waverley Glen and ErgoSafe, North America's leading supplier of lifting, handling and repositioning aid products and services across Canada and the US Freeway and Prism Service & Repair are leading suppliers of moving and handling products and services in the UK. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.
This document contains forward‐looking statements relating to our operations and to the environment in which we operate and our strategy, action plans and investments, which may involve estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and/or are beyond our control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward‐looking statements. These factors include those set forth in this report and our other public filings. Consequently, readers should not place any undue reliance on such forward‐looking statements. These forward‐looking statements are made as of the date of this report. Prism Medical is under no obligation to update any forward‐looking statements contained herein should material facts change due to new information, future events or other factors. All forward‐looking statements attributable to Prism Medical are expressly qualified by these cautionary statements.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.